Testosterone and low libido in women: what TikTok gets wrong

What's this video probably claiming?

An OB/GYN creator discussing decreased libido is almost certainly covering the role of testosterone in female sexual desire, likely framing low libido as underdiagnosed and undertreated. She's probably walking through how testosterone declines with age, after oophorectomy, or postpartum, and suggesting that testosterone therapy could be a legitimate option for women who've been dismissed by their doctors. Given the TRT hashtag, there's a reasonable chance she's referencing off-label testosterone use for women since the FDA has not approved a testosterone product for women in the United States. She may also be addressing male hypogonadism and libido in the same breath, given the caption mentions both sexes. The destigmatization framing suggests she's pushing back on providers who attribute low libido purely to psychological causes or relationship factors, which is a legitimate clinical frustration, but one that can slide into oversimplifying a genuinely complex picture if the nuance isn't there.

What does the science actually show?

The evidence for testosterone in women with hypoactive sexual desire disorder (HSDD) is actually more solid than most people realize. A 2019 systematic review and meta-analysis by Islam et al. in The Lancet Diabetes and Endocrinology, pooling data from 36 randomized trials and over 8,000 women, found that testosterone therapy significantly improved sexual function scores, desire, arousal, and orgasm frequency compared to placebo or estrogen alone. The effect sizes were modest but consistent. For context, the mean increase in satisfying sexual events per month was roughly 0.5 to 1 additional event, which sounds small but was statistically and clinically meaningful across populations. In men, testosterone replacement for confirmed hypogonadism (total testosterone below 300 ng/dL per Endocrine Society criteria) does improve libido, though a 2016 trial by Snyder et al. in the New England Journal of Medicine found effects on sexual function were positive but that benefits on other outcomes like mood and energy were weaker than commonly claimed.

Where does the social media noise diverge from clinical reality?

Here's where it gets messy. TikTok content on testosterone and libido tends to flatten a genuinely complicated diagnostic process into a simple hormone-optimization pitch. Low libido in women has multiple validated etiologies: relationship distress, depression, medication side effects (SSRIs are a major offender), thyroid dysfunction, genitourinary syndrome of menopause, and yes, androgen insufficiency. There is no agreed-upon lower limit of normal for testosterone in women, which the Endocrine Society explicitly acknowledged in its 2014 clinical practice guideline. Diagnosing androgen insufficiency in women remains contested. The social media version of this conversation often skips that diagnostic complexity entirely and moves straight to treatment, which is a problem. Pellet therapy in particular, popular on wellness TikTok, has no standardized dosing and has been associated with supraphysiologic testosterone levels and adverse effects including acne, hair loss, and clitoral hypertrophy in women, per a 2018 review by Snabes and Simes in Menopause.

What should you actually know?

If you're a woman experiencing low libido, the honest answer is that a thorough workup matters more than a prescription. HSDD is a real, validated diagnosis using tools like the Decreased Sexual Desire Screener (DSDS), and it affects an estimated 8 to 10 percent of premenopausal women and up to 12 to 14 percent of postmenopausal women per Clayton et al. (2018, International Journal of Women's Health). Flibanserin (Addyi), the only FDA-approved treatment specifically for HSDD in premenopausal women, has a modest effect size and real drug interaction risks with alcohol and CYP3A4 inhibitors. Testosterone off-label use can be appropriate in the right clinical context with monitoring, but it requires an informed prescriber, baseline labs, and follow-up testing. For men, if total testosterone is genuinely low and symptoms are present, TRT is supported by evidence. But if testosterone is in the normal range, adding more rarely fixes libido and introduces real cardiovascular and fertility considerations. This is a conversation worth having with a clinician, not a TikTok comment section.